IBDEI1BT ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23754,0)
 ;;=51720^^151^1513^6^^^^1
 ;;^UTILITY(U,$J,358.3,23754,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23754,1,2,0)
 ;;=2^51720
 ;;^UTILITY(U,$J,358.3,23754,1,3,0)
 ;;=3^Bladder Instill Anticarc
 ;;^UTILITY(U,$J,358.3,23755,0)
 ;;=J0897^^151^1513^11^^^^1
 ;;^UTILITY(U,$J,358.3,23755,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23755,1,2,0)
 ;;=2^J0897
 ;;^UTILITY(U,$J,358.3,23755,1,3,0)
 ;;=3^Denosumab Inj 1 mg
 ;;^UTILITY(U,$J,358.3,23756,0)
 ;;=J1950^^151^1513^18^^^^1
 ;;^UTILITY(U,$J,358.3,23756,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23756,1,2,0)
 ;;=2^J1950
 ;;^UTILITY(U,$J,358.3,23756,1,3,0)
 ;;=3^Leuprolide Acetate Susp 3.75 mg
 ;;^UTILITY(U,$J,358.3,23757,0)
 ;;=J3489^^151^1513^27^^^^1
 ;;^UTILITY(U,$J,358.3,23757,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23757,1,2,0)
 ;;=2^J3489
 ;;^UTILITY(U,$J,358.3,23757,1,3,0)
 ;;=3^Zoledronic Acid 1 mg
 ;;^UTILITY(U,$J,358.3,23758,0)
 ;;=J3490^^151^1513^23^^^^1
 ;;^UTILITY(U,$J,358.3,23758,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23758,1,2,0)
 ;;=2^J3490
 ;;^UTILITY(U,$J,358.3,23758,1,3,0)
 ;;=3^Unclassified Biologics
 ;;^UTILITY(U,$J,358.3,23759,0)
 ;;=J9031^^151^1513^4^^^^1
 ;;^UTILITY(U,$J,358.3,23759,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23759,1,2,0)
 ;;=2^J9031
 ;;^UTILITY(U,$J,358.3,23759,1,3,0)
 ;;=3^BCG
 ;;^UTILITY(U,$J,358.3,23760,0)
 ;;=J9155^^151^1513^10^^^^1
 ;;^UTILITY(U,$J,358.3,23760,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23760,1,2,0)
 ;;=2^J9155
 ;;^UTILITY(U,$J,358.3,23760,1,3,0)
 ;;=3^Degarelix 1 mg
 ;;^UTILITY(U,$J,358.3,23761,0)
 ;;=J9217^^151^1513^19^^^^1
 ;;^UTILITY(U,$J,358.3,23761,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23761,1,2,0)
 ;;=2^J9217
 ;;^UTILITY(U,$J,358.3,23761,1,3,0)
 ;;=3^Leuprolide Acetate Susp 7.5 mg
 ;;^UTILITY(U,$J,358.3,23762,0)
 ;;=J9218^^151^1513^16^^^^1
 ;;^UTILITY(U,$J,358.3,23762,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23762,1,2,0)
 ;;=2^J9218
 ;;^UTILITY(U,$J,358.3,23762,1,3,0)
 ;;=3^Leuprolide Acetate 1 mg
 ;;^UTILITY(U,$J,358.3,23763,0)
 ;;=J9219^^151^1513^17^^^^1
 ;;^UTILITY(U,$J,358.3,23763,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23763,1,2,0)
 ;;=2^J9219
 ;;^UTILITY(U,$J,358.3,23763,1,3,0)
 ;;=3^Leuprolide Acetate Implant 65 mg
 ;;^UTILITY(U,$J,358.3,23764,0)
 ;;=J0270^^151^1513^2^^^^1
 ;;^UTILITY(U,$J,358.3,23764,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23764,1,2,0)
 ;;=2^J0270
 ;;^UTILITY(U,$J,358.3,23764,1,3,0)
 ;;=3^Alprostadil 1.25 mcg
 ;;^UTILITY(U,$J,358.3,23765,0)
 ;;=J0275^^151^1513^3^^^^1
 ;;^UTILITY(U,$J,358.3,23765,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23765,1,2,0)
 ;;=2^J0275
 ;;^UTILITY(U,$J,358.3,23765,1,3,0)
 ;;=3^Alprostadil Urethral Suppository
 ;;^UTILITY(U,$J,358.3,23766,0)
 ;;=J2370^^151^1513^21^^^^1
 ;;^UTILITY(U,$J,358.3,23766,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23766,1,2,0)
 ;;=2^J2370
 ;;^UTILITY(U,$J,358.3,23766,1,3,0)
 ;;=3^Phenyleprhine HCL 1 mg
 ;;^UTILITY(U,$J,358.3,23767,0)
 ;;=J1212^^151^1513^8^^^^1
 ;;^UTILITY(U,$J,358.3,23767,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23767,1,2,0)
 ;;=2^J1212
 ;;^UTILITY(U,$J,358.3,23767,1,3,0)
 ;;=3^DMSO per 50 ml
 ;;^UTILITY(U,$J,358.3,23768,0)
 ;;=J9031^^151^1513^5^^^^1
 ;;^UTILITY(U,$J,358.3,23768,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23768,1,2,0)
 ;;=2^J9031
 ;;^UTILITY(U,$J,358.3,23768,1,3,0)
 ;;=3^BCG Intravesical per Instillation
 ;;^UTILITY(U,$J,358.3,23769,0)
 ;;=J9280^^151^1513^20^^^^1
 ;;^UTILITY(U,$J,358.3,23769,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23769,1,2,0)
 ;;=2^J9280
 ;;^UTILITY(U,$J,358.3,23769,1,3,0)
 ;;=3^Mitomycin 5 mg
